Antimicrobial Agents Research Group, School of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham, UK.
J Antimicrob Chemother. 2012 Mar;67(3):589-99. doi: 10.1093/jac/dkr515. Epub 2011 Dec 20.
The initial aim of this study was to use a systems biology approach to analyse a ciprofloxacin-selected multidrug-resistant (MDR) Salmonella enterica serotype Typhimurium, L664.
The whole genome sequence and transcriptome of L664 were analysed. Site-directed mutagenesis to recreate each mutation was carried out, followed by phenotypic characterization and mutation frequency analysis. As a mutation in the TCA cycle was detected we tested the controversial hypothesis regarding the bacterial response to bactericidal antibiotics, put forward by Kohanski et al. (Cell 2007; 130: 797-810 and Mol Cell 2010; 37: 311-20), that exposure of bacteria to agents such as ciprofloxacin produces reactive oxygen species (ROS), which transiently increase the mutation rate giving rise to MDR bacteria.
L664 contained a mutation in ramR that conferred MDR. A mutation in tctA affected the TCA cycle and conferred the inability to grow on minimal agar. The virulence of L664 was not attenuated. Ciprofloxacin exposure produced ROS in L664 and SL1344 (tctA::aph), but it was reduced and occurred later. There were no significant differences in the rates of killing or mutations per generation to antibiotic resistance between the strains.
Whilst we confirm production of ROS in response to ciprofloxacin, we have no data to support the hypothesis that this leads to selection of MDR strains. Our results indicate that the mutations in tctA and glgA were random as they did not pre-exist in the parental strain, and that the mutation in tctA did not provide a survival advantage or disadvantage in the presence of antibiotic.
本研究的最初目的是使用系统生物学方法分析环丙沙星选择的多重耐药(MDR)鼠伤寒沙门氏菌 L664。
分析了 L664 的全基因组序列和转录组。进行了重建每个突变的定点突变,然后进行表型特征分析和突变频率分析。由于检测到 TCA 循环中的突变,我们测试了 Kohanski 等人提出的关于细菌对杀菌抗生素反应的有争议的假设(Cell 2007; 130: 797-810 和 Mol Cell 2010; 37: 311-20),即暴露于环丙沙星等药物的细菌会产生活性氧(ROS),这会暂时增加突变率,从而产生 MDR 细菌。
L664 中存在 ramR 突变,赋予其 MDR 特性。tctA 中的突变影响 TCA 循环,并导致无法在最小琼脂上生长。L664 的毒力没有减弱。环丙沙星暴露会在 L664 和 SL1344(tctA::aph)中产生 ROS,但减少且发生较晚。两种菌株对抗生素的杀伤率或每代耐药性突变率均无显着差异。
虽然我们证实了环丙沙星反应产生了 ROS,但我们没有数据支持这会导致选择 MDR 菌株的假设。我们的结果表明,tctA 和 glgA 中的突变是随机的,因为它们在亲本菌株中不存在,并且 tctA 中的突变在存在抗生素的情况下没有提供生存优势或劣势。